WebBackground: The mechanism of chemoresistance remains unknown. Here, we investigated if glucose transporter-1 (GLUT-1) and PI3K/Akt pathways are associated with the sensitivity to cisplatin in Hep-2 laryngeal carcinoma cells and whether the inhibition of GLUT-1 and the PI3K/Akt pathways enhances the chemosensitivity of Hep-2 cells. … WebApr 21, 2024 · Anaphylaxis and severe hypersensitivity reactions characterized by dyspnea and hypotension requiring treatment, angioedema, and generalized urticaria have occurred in 2 to 4% of patients receiving Taxol in clinical trials. Fatal reactions have occurred in patients despite premedication.
Infusion reactions to systemic chemotherapy - UpToDate
WebApr 5, 2024 · Known hypersensitivity to active ingredients or excipients of the study drug, such as envafolimab and cisplatin; Subjects who have concomitant diseases that, in the investigator 's judgment, would seriously jeopardize the subject' s safety or affect the completion of the study, or who are considered unsuitable for enrollment for other reasons. WebIt remains a priority to increase the sensitivity of tumor cells to cisplatin-based chemotherapy or to identify new regimens for antitumor adjuvant treatment. ... All cells were treated with the same master mix and in the same reaction vessel. This droplet-based system uses barcodes (1 for each cell) and unique molecular identifiers (UMIs, 1 ... grand cherokee tow package
Risk Factors of Hypersensitivity to Carboplatin in Patients with ...
WebSep 18, 2024 · NCBI Bookshelf WebSep 21, 2016 · Thirteen patients (54%) developed at least moderately severe symptoms (diffuse erythroderma, tachycardia, chest tightness, wheezing, facial swelling, dyspnea, hypertension, or hypotension). In approximately one half of patients, the reaction developed after more than 50% of the carboplatin had been infused. WebJun 3, 2024 · Cisplatin injection can cause severe hypersensitivity reactions, including anaphylaxis and death. Manifestations have included facial edema, wheezing, tachycardia, and hypotension. Hypersensitivity reactions have occurred within minutes of administration to patients with prior exposure tocisplatin injection. chinese belt initiative